Sandbox carlos: Difference between revisions
Jump to navigation
Jump to search
Carlos Lopez (talk | contribs) No edit summary |
Carlos Lopez (talk | contribs) No edit summary |
||
| Line 9: | Line 9: | ||
::* 2. '''Outpatient treatment''' | ::* 2. '''Outpatient treatment''' | ||
::*1. Previously healthy and no risk factors for drug-resistant Streptococcus pneumoniae infection: | ::*1. Previously healthy and no risk factors for drug-resistant Streptococcus pneumoniae infection: | ||
:::* Preferred regimen:[[Macrolides]] ([[azithromycin]], [[clarithromycin]], {{or}} [[erythromycin]]) (strong recommendation) level I evidence | :::* Preferred regimen:[[Macrolides]] ([[azithromycin]], [[clarithromycin]], {{or}} [[erythromycin]]) (strong recommendation) level I evidence | ||
:::* Alternative regimen: [[Doxycycline]] | :::* Alternative regimen: [[Doxycycline]] | ||
::* 3. ''''''Inpatient, non-ICU treatment''' | |||
:::* Preferred regimen: | |||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
Revision as of 20:29, 14 July 2015
- Mycoplasma pneumoniae
Return to Top
-
- 1. Community-acquired pneumonia
- Preferred regimen: Macrolide OR Tetracycline
- Alternative regimen: Fluoroquinolone
- 2. Outpatient treatment
- 1. Previously healthy and no risk factors for drug-resistant Streptococcus pneumoniae infection:
- Preferred regimen:Macrolides (azithromycin, clarithromycin, OR erythromycin) (strong recommendation) level I evidence
- Alternative regimen: Doxycycline
- 3. 'Inpatient, non-ICU treatment
- Preferred regimen:
References
- ↑ Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC; et al. (2007). "Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults". Clin Infect Dis. 44 Suppl 2: S27–72. doi:10.1086/511159. PMID 17278083.
- ↑ Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.